Vaxart

(OTC) VXRT

Current Price$0.76

Market Cap$182.93M

Since IPO (2018)-91%

5 Year-89%

1 Year+82%

1 Month+24%

Vaxart Financials at a Glance

Market Cap

$182.93M

Revenue (TTM)

$237.26M

Net Income (TTM)

$16.33M

EPS (TTM)

$0.06

P/E Ratio

12.78

Dividend

$0.00

Beta (Volatility)

1.73 (High)

Dividend

$0.00

Beta (Volatility)

1.73 (High)

Price

$0.76

Volume

399,818

Open

$0.77

Price

$0.76

Volume

399,818

Open

$0.77

Previous Close

$0.76

Daily Range

$0.75 - $0.78

52-Week Range

$0.26 - $0.84

Dividend

$0.00

Beta (Volatility)

1.73 (High)

Price

$0.76

Volume

399,818

Open

$0.77

Previous Close

$0.76

Daily Range

$0.75 - $0.78

52-Week Range

$0.26 - $0.84

VXRT News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vaxart

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Steven Lo

Website

vaxart.com

Headquarters

South San Francisco, CA 94080, US

VXRT Financials

Key Financial Metrics (TTM)

Gross Margin

90%

Operating Margin

Net Income Margin

Return on Equity

22%

Return on Capital

11%

Return on Assets

Earnings Yield

7.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$182.93M

Shares Outstanding

241.41M

Volume

399.82K

Avg. Volume

479.86K

Financials (TTM)

Gross Profit

$237.26M

Operating Income

$18.07M

EBITDA

$28.20M

Operating Cash Flow

$7.71M

Capital Expenditure

$145.00K

Free Cash Flow

$7.57M

Cash & ST Invst.

$63.81M

Total Debt

$8.98M

Vaxart Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$104.24M

+586.5%

Gross Profit

$81.48M

+436.6%

Gross Margin

78.17%

N/A

Market Cap

$182.93M

N/A

Market Cap/Employee

$1.74M

N/A

Employees

105

N/A

Net Income

$55.05M

+559.3%

EBITDA

$57.99M

+770.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$54.82M

+92.8%

Accounts Receivable

$51.34M

+329.0%

Inventory

$0.00

N/A

Long Term Debt

$6.01M

-62.8%

Short Term Debt

$5.96M

-16.5%

Return on Assets

8.77%

N/A

Return on Invested Capital

10.99%

N/A

Free Cash Flow

$30.66M

+515.0%

Operating Cash Flow

$30.66M

+517.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

UNCYUnicycive Therapeutics, Inc.

UNCYUnicycive Therapeutics, Inc.$8.08+1.25%

RPTXRepare Therapeutics Inc.

RPTXRepare Therapeutics Inc.$2.65+0.00%

IMUXImmunic, Inc.

IMUXImmunic, Inc.$11.28+6.21%

CAMPCAMP4 Therapeutics Corporation

CAMPCAMP4 Therapeutics Corporation$3.98+3.11%

FBIOFortress Biotech, Inc.

FBIOFortress Biotech, Inc.$2.46+3.36%

PMVPPMV Pharmaceuticals, Inc.

PMVPPMV Pharmaceuticals, Inc.$1.37-2.14%

CBUSCibus, Inc.

CBUSCibus, Inc.$1.54+3.36%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

DGXXDigi Power X

DGXXDigi Power X$5.11+0.29%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.96-0.02%

CCLCarnival Corp.

CCLCarnival Corp.$25.77+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.81+0.02%

RIGTransocean

RIGTransocean$6.25-0.09%

CIFRCipher Mining

CIFRCipher Mining$22.10+0.24%

PINSPinterest

PINSPinterest$22.28+0.07%

Questions About VXRT

What is the current price of Vaxart?

Vaxart is trading at $0.76 per share.

What is the 52-week range for Vaxart?

Over the past 52 weeks, Vaxart has traded between $0.26 and $0.84.

How much debt does Vaxart have?

As of the most recent reporting period, Vaxart reported total debt of $13.04M.

How much cash does Vaxart have on hand?

Vaxart reported $53.81M in cash and cash equivalents in its most recent financial results.

What is Vaxart’s dividend yield?

Vaxart does not currently have a dividend yield.

Vaxart

Vaxart Financials at a Glance

VXRT News

Vaxart Revenue Jumps 520% in Fiscal Q2

Could This Unknown Stock Beat Moderna in 2023?

3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

Can This 1 Thing Hurt Vaxart?

Is Vaxart the Next Moderna?

3 No-Brainer Stocks to Buy Right Now for Less Than $6

Is It Too Late to Buy Vaxart Stock?

These 19 Words From Vaxart Could Mean Trouble for Vaccine Rivals

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Vaxart

VXRT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Vaxart Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VXRT

What is the current price of Vaxart?

What is the 52-week range for Vaxart?

How much debt does Vaxart have?

How much cash does Vaxart have on hand?

What is Vaxart’s dividend yield?

Premium Investing Services